The Two Areas Where Large-Scale Cannabis Farming is Legal in California
Ash Stringer
December 3rd, 2019
App, Exclusive, News
Famously known for its vineyards, the rolling hills of Santa Barbara, California and, 200 miles to the north, the Salinas Valley, once the rose capital of the world, have transformed into new commerce hubs: cannabis. As the only areas of California currently allowing large-scale cannabis cultivation, companies looking to get an upper hand on market share have targeted operations in Santa Barbara and the Salinas Valley. One of those is Paul King, who founded Cannafornia Holdings to capitalize on the burgeoning market in the world’s fifth largest economy.
Against this backdrop, the California Central Coast is rivaling the popular Emerald Triangle at the northern part of the state as the U.S. epicenter for marijuana cultivation. “The Central Coast may be newer to the game, but it enjoys distinct advantages with accessibility, flat geography, perfect climate and an expansive labor pool with agricultural experience,” King told CFN Media in a phone conversation. “And, of course, there are all the greenhouses and all their infrastructure that made Salinas particularly attractive for us to set up shop,” he added.
Cannafornia’s Greenhouse in Stunning Salinas Valley California
King, 35, knows an opportunity when he sees one. A tech innovator and serial entrepreneur, he founded and built the mobile phone charging technology company goCharge into the #1 company in its space after graduating Summa Cum Laude from Carnegie Mellon University. Those efforts, among others have resulted in King being featured on CNN News, NBC, BusinessWeek, MediaWeek and earned him the distinction of being named to BusinessWeek’s 25 Under 25 Entrepreneurs.
Accredited? Click here to receive an investor deck and corporate updates
Off Ran the Roses
In the Salinas Valley, the fertile soil and salty breeze provide ideal growing conditions for a variety of plants. Known as the “Salad Bowl” due to the fact that 70% of the U.S.’s lettuce comes from the region, it also used to serve as the nation’s premier source for roses. However, expanded free trade agreements and Americans’ incessant quest for less expensive products caused rose production in the U.S. to plunge about 95% since 1991, creating a massive rose industry in Colombia and leaving thousands of greenhouses vacant in California.
With the genesis of the legal marijuana industry, lawmakers in the Salinas Valley implemented accommodative policy to put the greenhouses back into use, bucking a wider trend in California to only allow small-scale cultivators. The Salinas governments began approving cultivation licenses for multiple greenhouses on a property with one owner, effectively creating some of the largest cannabis farms in the country.
As it happens, the climate and infrastructure needed for roses dovetails perfectly with cannabis cultivation. The optimal growing conditions (250+ days of sunshine) and ample labor facilitate growing top-shelf cannabis buds at a relatively low expense.
Just Add Water
From seed to flower, Cannafornia handles the entire production process in house, with water being the only outside element. This essentially eliminates the risk of any contamination while producing premium, pesticide-free OG cannabis. OG is cannabis nomenclature for world-renowned handcrafted California marijuana, with a commonly accepted definition of the acronym being “Ocean Grown.”
All told, Cannafornia now has approximately 146,000 square feet of greenhouse cultivation space, 35,000 sq. ft. of nursery space, and 11,000 sq. ft. for processing and manufacturing. At the facilities, the company produces different types of flowers, including indica, sativa and hybrids.
Going forward, the company is expanding its already formidable manufacturing and cultivation footprint. This includes operating two facilities in Salinas with 600,000 square feet of greenhouses, a THC processing plant in Long Beach, CBD processing facility in Sacramento, and eventually a 270-acre farm in Florida.
Accredited? Click here to receive an investor deck and corporate updates
Presently, the company has a total of 16 licenses covering cultivation, nursery, processing, manufacturing, delivery and retail.
Before Cannafornia products – currently consisting of flowers, pre-rolls, oil cartridges and disposable pens – make it to retail shelves, they go through independent laboratory testing to analyze THC (tetrahydrocannabinol) content, CBD (cannabinoid) levels and to verify the lack of any contaminants. The brand is already on the shelves at over 50 of 700 licensed dispensaries in California.
According to King in a corporate video, Cannafornia has a goal to bring great quality, organic cannabis into people’s lives whether it is for medical use for glaucoma, arthritis, cancer, seizures or even as a mood enhancer to help users get through the day. “It really helps a lot of people…If they just knew about it and gave it a chance,” he says.
Ultimately, management has a goal to continue expansion to become one of the largest distributors of cannabis products in California.
Horizontal Growth
As part of the growth plan, Cannafornia’s CBD division is opening a new certified food manufacturing facility in Sacramento for the purpose of manufacturing CBD products under Good Manufacturing Practices (GMP). The facility will also include an R&D lab for new product development, including tinctures, capsules, edibles, inhalers, and pet products.
Cannafornia’s CBD Balm
With hemp-derived CBD legalized in the U.S. at the start of 2019 through the passage of the 2018 Farm Bill, interstate and international commerce is now open. Cannafornia, which already has a CBD balm on the market, is taking a unique approach with its strategy of launching feminine CBD products during Q1 2020. The goal is to sell products in national chains like Walmart, Target, Walgreens, CVS, Rite Aid, Bed, Bath and Beyond and others, while targeting international distribution beginning with Latin America and Europe.
CBD, a non-intoxicating compound of cannabis sativa, is widely publicized for its potential therapeutic benefits. By definition hemp contains little to no THC, the part of cannabis responsible for the psychoactive high. Athletes from all walks of life are touting the benefits of CBD in pain management and muscle recovery, amongst other things.
Social Media Heavyweight
Across its brands and 13 user accounts, Cannafornia has more than 1 million followers on social media. But, that’s only the start of the breadth of the exposure the brand receives.
The new CBD division was unveiled only six weeks ago and all the basic blocking and tackling to establish the Cannafornia brand is showing through immediately. The wellness-focused unit initially partnered with UFC welterweight champion Colby “Chaos” Covington as a brand ambassador. Covington trumpets the recovery effect of Cannafornia’s CBD balm, claiming “CBD changed my life.”
UFC welterweight champion Colby “Chaos” Covington Cannafornia’s CBD Brand Ambassador
Covington’s signing was followed shortly thereafter by the launch of the Cannafornia Fight Team, which involved the addition of:
- Derrick Lewis (aka The Black Beast) – Heavyweight
- Jairzinho Rozenstruik (aka “Bigi Boy”) – Heavyweight
- Jared Cannonier (aka “The Killa Gorilla”) – Middleweight
- Isaac Thomson (a.k.a. Ice Cold) –Bantamweight
- Anna Maria Verbeek (a.k.a. “Fight Queen) – Strawweight
Across social media platforms, the addition of the elite athletes promotes Cannafornia to hundreds of thousands of more consumers, which should continue to drive brand awareness concurrent with corporate expansion efforts.
Accredited? Click here to receive an investor deck and corporate updates
To Learn more about Cannafornia please visit the website
Click Here to Receive CFN Media’s Newsletter Every Week in Your Inbox
Disclaimer
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ash Stringer
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
In addition to his role as Founder and CEO at MAZAKALI, Sumit is a consultant to The Arcview Group and the Managing Partner of Emerald Ventures. A frequent speaker at investment seminars, Sumit acts as a mentor to Arcview and Canopy companies and serves on the Canopy Investment committee as well as the NCIA Finance […]
Technical420 is the premier provider of research and analysis on cannabis stocks. We provide investors with sponsored and non-sponsored information on the volatile and emerging cannabis industry. “Our research is our passion!” Your profit is our reward!
Lexaria Corp is an aspiring producer of medical marijuana under Canada’s Marihuana for Medical Purposes Regulations (“MMPR”). On March 5, 2014, the company signed a joint venture with Enertopia Corp. (OTC: ENRT) (CSE: TOP) with the goal of bringing a 60,000 square foot cultivation facility online.
Tryp Therapeutics is a pharmaceutical company focused on developing compounds with known activity and/or safety profiles for the treatment of rare diseases and other diseases with high unmet medical needs.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
